Having featured multimode light detection technology as part of its screening systems for several years, Molecular Devices has finally collected the necessary IP to protect particular methods surrounding the technology.

Late last month, the company was awarded US Patent No. 6,825,921, entitled “Multi-mode light detection system.” According to Todd French, Molecular Devices’ director of research, the methods described in the patent pertain to the company’s Analyst line of screening systems, which includes the analyst GT, HT, and AD products.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.